Department of Urology, and University of California, Irvine, Orange, California, USA.
Department of Epidemiology, University of California, Irvine, Orange, California, USA.
J Endourol. 2021 Dec;35(12):1785-1792. doi: 10.1089/end.2020.1164.
Robot-assisted radical nephrectomy (RRN) is increasingly utilized as an alternative to laparoscopic radical nephrectomy (LRN), but there are concerns over costs and objective benefit. In the setting of very large renal masses (>10 cm), comparison between techniques is limited and it is unclear whether a robotic approach confers any perioperative benefit over LRN or open radical nephrectomy (ORN). In this study, perioperative outcomes of RRN, LRN, and ORN for very large renal masses are compared. Using the National Cancer Database, patients were identified who underwent radical nephrectomy for kidney tumors >10 cm diagnosed from 2010 to 2015. Patients were analyzed according to surgical approach. Perioperative outcomes, including conversion to open, length of stay, readmission rates, positive surgical margins, and 30- and 90-day mortality were compared among cohorts. A total of 9288 patients met inclusion criteria (RRN = 842, LRN = 2326, ORN = 6120). Compared with ORN, recipients of RRN or LRN had similar rates of 30-day readmission and 30- and 90-day mortality. Length of hospital stay was significantly shorter in RRN (-1.73 days ±0.19; < 0.0001) and LRN (-1.40 days ±0.12; < 0.0001) compared with ORN. LRN had a higher rate of conversion to open compared with RRN (odds ratio 1.48; 95% confidence interval 1.10-1.98; = 0.0087). Conversion to open from RRN or LRN added 1.3 additional days of inpatient stay. Over the study period, RRN use increased from 4.1% to 14.8%, LRN from 20.9% to 25.6%, whereas ORN use decreased from 75% to 59.6%. Minimally invasive approaches are increasingly utilized in very large renal masses. RRN has lower rates of conversion to open but produces comparable perioperative outcomes to LRN. Minimally invasive approaches have a shorter length of inpatient stay but otherwise report similar surgical margin status, readmission rates, and mortality rates compared with ORN.
机器人辅助根治性肾切除术(RRN)越来越多地被用作腹腔镜根治性肾切除术(LRN)的替代方法,但人们对成本和客观获益存在担忧。在非常大的肾肿瘤(> 10 cm)的情况下,两种技术的比较受到限制,并且尚不清楚机器人方法是否比 LRN 或开放性根治性肾切除术(ORN)具有任何围手术期优势。在这项研究中,比较了 RRN、LRN 和 ORN 治疗非常大的肾肿瘤的围手术期结果。利用国家癌症数据库,确定了 2010 年至 2015 年间诊断出> 10 cm 的肾肿瘤患者,并接受了根治性肾切除术。根据手术方式对患者进行分析。比较了队列之间的围手术期结果,包括转为开放性手术、住院时间、再入院率、阳性切缘以及 30 天和 90 天死亡率。共有 9288 名患者符合纳入标准(RRN=842,LRN=2326,ORN=6120)。与 ORN 相比,接受 RRN 或 LRN 的患者的 30 天再入院率以及 30 天和 90 天死亡率相似。与 ORN 相比,RRN(-1.73 天±0.19; < 0.0001)和 LRN(-1.40 天±0.12; < 0.0001)的住院时间明显缩短。与 RRN 相比,LRN 转为开放性手术的比例更高(优势比 1.48;95%置信区间 1.10-1.98; = 0.0087)。从 RRN 或 LRN 转为开放性手术增加了 1.3 天的住院时间。在研究期间,RRN 的使用率从 4.1%增加到 14.8%,LRN 从 20.9%增加到 25.6%,而 ORN 的使用率从 75%下降到 59.6%。微创方法越来越多地用于治疗非常大的肾肿瘤。RRN 转为开放性手术的比例较低,但与 LRN 相比,围手术期结果相似。微创方法的住院时间较短,但与 ORN 相比,在切缘状态、再入院率和死亡率方面报告相似。